Implantable Pulse Generator Market Report 2026

Implantable Pulse Generator Market Overview

• Implantable Pulse Generator market size has reached to $147.01 billion in 2025 • Expected to grow to $245.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.8% • Growth Driver: Impact Of Neurological Disorders On Implantable Pulse Generator Market Growth • Market Trend: MRI Conditional, Closed Loop Neurostimulators Enhance Therapy Personalization And Patient Safety • North America was the largest region in 2025.

What Is Covered Under Implantable Pulse Generator Market?

An implantable pulse generator (IPG) refers to a medical device used to deliver electrical impulses to specific nerves or muscles within the body. It is commonly used in neuromodulation therapies to manage conditions such as chronic pain or movement disorders. The IPG is surgically implanted under the skin and can be programmed to adjust stimulation levels as needed. The main products of Implantable pulse generator are implantable cardiac pacemakers, implantable defibrillators, cochlear implants, implantable nerve stimulators (FES), implantable infusion pumps, and implantable active monitoring devices. Implantable cardiac pacemakers are medical devices surgically placed in the chest to regulate abnormal heart rhythms by delivering electrical impulses to stimulate the heart. These devices come in rechargeable and non-rechargeable types and are applied in cardiovascular diseases, movement disorders, orthopedic diseases, and other conditions. The end users include hospitals, ambulatory surgical centers, home care settings, and clinics.

What Is The Implantable Pulse Generator Market Growth Forecast?

The implantable pulse generator market size is expected to see rapid growth in the next few years. It will grow to $245.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, growing aging population, rising burden of neurological disorders, expanding access to advanced implantable therapies, increasing focus on long-term disease management. Major trends in the forecast period include growing adoption of neuromodulation therapies, rising use of implantable pulse generators for chronic pain management, increasing preference for rechargeable implantable pulse generators, expansion of implantable pulse generator applications in movement disorders, growing demand for long-term implantable stimulation devices.

Global Implantable Pulse Generator Market Segmentation

1) By Product Type: Functional Electrical Stimulation (FES) Devices for Motor Function Restoration, Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices 2) By Charging Type: Rechargeable, Non-Rechargeable 3) By Application: Movement Disorders, Chronic Pain Management, Neurological Disorders, Other Applications 4) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Home Care and Remote Monitoring Settings Subsegments: 1) By Functional Electrical Stimulation (FES) Devices: For Motor Function Restoration, For Muscle Strengthening, For Rehabilitation Post-Stroke or Injury 2) By Spinal Cord Stimulation (SCS) Devices: Conventional SCS Systems, High-Frequency SCS Systems, Burst SCS Systems 3) By Deep Brain Stimulation (DBS) Devices: Parkinson’s Disease DBS Systems, Essential Tremor DBS Systems, Dystonia DBS Systems, Other Neurological Disorder DBS Systems 4) By Vagus Nerve Stimulation (VNS) Devices: Epilepsy Treatment VNS Devices, Depression Treatment VNS Devices 5) By Sacral Nerve Stimulation (SNS) Devices: Urinary Incontinence SNS Devices, Fecal Incontinence SNS Devices, Other Pelvic Floor Disorder SNS Devices

What Is The Driver Of The Implantable Pulse Generator Market?

A rise in the incidence of neurological disorders is expected to propel the growth of the implantable pulse generator market going forward. Neurological disorders refer to conditions affecting the brain, spinal cord, and nervous system, impacting functions such as movement, sensation, and cognition. Increasing cases of neurological disorders are often attributed to factors such as aging populations, lifestyle changes, environmental influences, and improved diagnostic techniques. Implantable pulse generators help with neurological disorders by delivering targeted electrical impulses to modulate abnormal neural activity and alleviate symptoms. For instance, in October 2023, according to the World Federation of Neurology, a UK-based non-profit organization, our study revealed that more than 40% of the global population currently experiences a neurological condition, and this burden is expected to nearly double in the coming years. Therefore, the rise in the incidence of neurological disorders is driving the growth of the implantable pulse generator industry.

Key Players In The Global Implantable Pulse Generator Market

Major companies operating in the implantable pulse generator market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Nevro Corp, LivaNova PLC, NeuroPace Inc, NeuroSigma Inc, Saluda Medical Pty Ltd, Synapse Biomedical Inc, Nuvectra Medical Inc, MainStay Medical International PLC, Aleva Neurotherapeutics SA, Bioness Inc, EnteroMedics Inc, Neuronetics Inc, Axonics Inc, Sceneray Co Ltd, Cirtec Medical, BlueWind Medical, Syntach AB, Osaka Medical Devices, Gimer Medical, Saluda Medical

Global Implantable Pulse Generator Market Trends and Insights

Major companies in the implantable pulse generator (IPG) market are prioritizing MRI conditional, neurostimulators, such as sensing-enabled rechargeable IPGs, to strengthen their competitive edge. For instance, in April 2024, Medtronic, a US-based healthcare company, received FDA approval for its Inceptiv closed-loop spinal cord stimulator, which monitors evoked compound action potentials (ECAPs) 50 times per second to adjust stimulation in real time while allowing full-body 1.5 T and 3 T MRI scans. Similarly, in January 2024, Medtronic introduced the Percept RC rechargeable deep brain stimulation neurostimulator, featuring BrainSense sensing technology, a 15-year battery life, and full-body MRI compatibility at 1.5 T and 3 T with therapy active. These advancements enhance therapy personalization and patient safety, though they may involve higher development and device costs.

What Are Latest Mergers And Acquisitions In The Implantable Pulse Generator Market?

In October 2025, Boston Scientific Corporation, a US-based health technology company, acquired Nalu Medical, Inc. for an undisclosed amount. With this acquisition. Boston Scientific Corporation’s aim is to expand and enhance its neuromodulation portfolio for chronic pain management. Nalu Medical, Inc. is a US-based medical equipment manufacturer company that provides implantable pulse generators.

Regional Outlook

North America was the largest region in the implantable pulse generator market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Implantable Pulse Generator Market?

The implantable pulse generator market consists of sales of neurostimulators, sacral nerve stimulators, and deep brain stimulation (DBS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.